We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




TIRFM Microscopy Shows Cell Processes

By Biotechdaily staff writers
Posted on 12 Mar 2006
A new family of objectives has been specifically designed for total internal reflection fluorescent microscopy (TIRFM), which selectively visualizes processes and structures of cell membranes. More...
The objectives have magnifications between 60x and 150x, and high numerical apertures (NAs) including an NA of 1.65.

High NAs allow laser light to attain the critical angle required for total internal reflection at the cover slip-medium interface. This induces an evanescent field that excites only fluorophores at the interface. Unlike standard wide-field microscopy, light does not travel through the specimens, photo-damage is reduced, and cells are able to live longer. A higher NA enables a shallower laser light angle and reduces penetration depth of the evanescent field.

The series of TIRFM objectives was developed by Olympus (Hamburg, Germany) for live-cell surface observations. The high NA of the Apo 100xOHR reduces the penetration depth to below 100 nm, providing a very fine depth of focus for precise observations of cell surface and membrane-associated processes. This is achieved through a very high signal-to-background ratio and a z-resolution that is not even achieved by confocal microscopy. There is a total absence of any out-of-focus fluorescence, as excitation occurs only in the plane of observation directly adjacent to the cover-slip medium interface.

Other new Olympic objectives are the Plapon 60xO (NA 1.45) and the Plapo 100xO (NA 1.45), developed for conventional TIRFM applications. The Uapo 150xO (NA 1.45) objective, with its high magnification, was developed for single molecule applications. Like the Plapon 60xO objective, it also features a compensation collar for varying temperature and cover slip thickness.

The modular approach to TIRFM imaging stations that encompasses all necessary components enables Olympus to provide completely integrated systems. The series of TIRFM objectives, a range of lasers, and several multi-port illuminators enable users to tailor their systems to their own applications.




Related Links:
Olympus Europe

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.